Skip to content

Neurocognitive Impact of Hypoglycemia in Type 1 Diabetes

Neurocognitive Impact of Hypoglycemia in Type 1 Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00916838
Acronym
HYPO
Enrollment
187
Registered
2009-06-10
Start date
2003-01-31
Completion date
2017-02-28
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes Mellitis

Keywords

Type 1 Diabetes Mellitis, MRI

Brief summary

125 children with Type 1 Diabetes mellitis (T1DM) between 4 and 16 were recruited and 62 healthy siblings also enrolled in the study. Children with T1DM and sibling controls ages 4 to 16 were assessed on memory and executive control skills at entry to the study (Test 1) and after two years of close monitoring for blood sugar events (Test 2). Diabetic children have their blood sugar tested directly before and after cognitive testing to ensure their blood sugar is within range during the testing. The 2-year follow-up period involves parents/child reporting any severe diabetic episode and periodically providing the results of the diabetic child's usual blood tests from their glucose monitoring device. Children 7 and older also underwent high resolution MRI scans.

Interventions

None listed

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
Washington University School of Medicine
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
4 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 4 - 16 (for MRI, must be 7 or older)

Exclusion criteria

* Pregnant or lactating (females 13+) * Chronic disease other than T1DM, well-controlled asthma, or Hashimoto's thyroiditis. (Exclude for hypothyroidism) * Other current serious medical illness * Co-morbid psychiatric illness: such as mania, ADHD, LD, major depression, mental retardation, or psychoactive drug dependence * Co-morbid neurological illness: stroke, seizure, major loss of consciousness, other brain trauma/surgery, or head injuries (i.e. near drowning), encephalitis, or hydrocephalus, blindness, deafness * EXCEPT T1DM-related * Pre-maturity at birth \>4 wks early (\<36 wk term) w/ sequelae e.g. on respirator at NICU * Use of psychoactive medications or exposure to neuroleptics (except that exposures of less than 1 month, occurring more than 5 years ago, will be allowed) or pts. w/recent tx w/dopamine depleting agents or stimulants such as Ritalin, Cylert, Adderall * Contraindication to MRI scan (e.g. claustrophobia, metal implants, foreign bodies) - N/A if \< 4 years old * Full set (top and bottom) orthodontic braces. (Half set braces, fillings, and retainers are OK)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026